Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

INDV vs AVPT vs QLYS vs RBBN vs TENB

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
INDV
Indivior Pharmaceuticals Inc

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$4.94B
5Y Perf.+890.0%
AVPT
AvePoint, Inc.

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$2.23B
5Y Perf.+5.4%
QLYS
Qualys, Inc.

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$3.34B
5Y Perf.-17.7%
RBBN
Ribbon Communications Inc.

Telecommunications Services

Communication ServicesNASDAQ • US
Market Cap$472M
5Y Perf.-38.9%
TENB
Tenable Holdings, Inc.

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$2.47B
5Y Perf.-31.1%

INDV vs AVPT vs QLYS vs RBBN vs TENB — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
INDV logoINDV
AVPT logoAVPT
QLYS logoQLYS
RBBN logoRBBN
TENB logoTENB
IndustryDrug Manufacturers - Specialty & GenericSoftware - InfrastructureSoftware - InfrastructureTelecommunications ServicesSoftware - Infrastructure
Market Cap$4.94B$2.23B$3.34B$472M$2.47B
Revenue (TTM)$1.29B$444M$685M$826M$1.02B
Net Income (TTM)$251M$47M$201M$31M$-12M
Gross Margin83.1%73.7%83.1%48.7%78.2%
Operating Margin33.3%9.6%33.7%-0.7%2.9%
Forward P/E12.7x27.7x12.9x20.7x11.1x
Total Debt$351M$10M$97M$405M$466M
Cash & Equiv.$195M$481M$250M$96M$188M

INDV vs AVPT vs QLYS vs RBBN vs TENBLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

INDV
AVPT
QLYS
RBBN
TENB
StockMay 20May 26Return
Indivior Pharmaceut… (INDV)100990.0+890.0%
AvePoint, Inc. (AVPT)100105.4+5.4%
Qualys, Inc. (QLYS)10082.3-17.7%
Ribbon Communicatio… (RBBN)10061.1-38.9%
Tenable Holdings, I… (TENB)10068.9-31.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: INDV vs AVPT vs QLYS vs RBBN vs TENB

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: QLYS leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Indivior Pharmaceuticals Inc is the stronger pick specifically for recent price momentum and sentiment. AVPT and TENB also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
INDV
Indivior Pharmaceuticals Inc
The Long-Run Compounder

INDV is the #2 pick in this set and the best alternative if long-term compounding is your priority.

  • 281.7% 10Y total return vs QLYS's 267.2%
  • +244.9% vs AVPT's -40.0%
Best for: long-term compounding
AVPT
AvePoint, Inc.
The Growth Play

AVPT ranks third and is worth considering specifically for growth exposure.

  • Rev growth 26.9%, EPS growth 193.8%, 3Y rev CAGR 21.8%
  • 26.9% revenue growth vs RBBN's 1.3%
Best for: growth exposure
QLYS
Qualys, Inc.
The Income Pick

QLYS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • beta 0.53
  • Lower volatility, beta 0.53, Low D/E 17.3%, current ratio 1.41x
  • Beta 0.53, current ratio 1.41x
  • 29.4% margin vs TENB's -1.2%
Best for: income & stability and sleep-well-at-night
RBBN
Ribbon Communications Inc.
The Communication Services Pick

Among these 5 stocks, RBBN doesn't own a clear edge in any measured category.

Best for: communication services exposure
TENB
Tenable Holdings, Inc.
The Value Play

TENB is the clearest fit if your priority is value.

  • Lower P/E (11.1x vs 20.7x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthAVPT logoAVPT26.9% revenue growth vs RBBN's 1.3%
ValueTENB logoTENBLower P/E (11.1x vs 20.7x)
Quality / MarginsQLYS logoQLYS29.4% margin vs TENB's -1.2%
Stability / SafetyQLYS logoQLYSBeta 0.53 vs RBBN's 1.49, lower leverage
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)INDV logoINDV+244.9% vs AVPT's -40.0%
Efficiency (ROA)QLYS logoQLYS19.1% ROA vs TENB's -0.7%, ROIC 47.5% vs 0.2%

INDV vs AVPT vs QLYS vs RBBN vs TENB — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

INDVIndivior Pharmaceuticals Inc
FY 2025
Reportable Segment
100.0%$1.2B
AVPTAvePoint, Inc.
FY 2024
SaaS
76.1%$319M
Termed License and Support
10.7%$45M
Service
10.5%$44M
Maintenance
2.7%$11M
QLYSQualys, Inc.
FY 2025
Reportable Segment
100.0%$669M
RBBNRibbon Communications Inc.
FY 2025
Cloud and Edge
60.6%$511M
IP Optical Networks
39.4%$333M
TENBTenable Holdings, Inc.
FY 2025
Subscription and Circulation
92.0%$920M
License and Maintenance
4.5%$45M
Service, Other
3.5%$35M

INDV vs AVPT vs QLYS vs RBBN vs TENB — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLINDVLAGGINGTENB

Income & Cash Flow (Last 12 Months)

QLYS leads this category, winning 3 of 6 comparable metrics.

INDV is the larger business by revenue, generating $1.3B annually — 2.9x AVPT's $444M. QLYS is the more profitable business, keeping 29.4% of every revenue dollar as net income compared to TENB's -1.2%. On growth, AVPT holds the edge at +26.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricINDV logoINDVIndivior Pharmace…AVPT logoAVPTAvePoint, Inc.QLYS logoQLYSQualys, Inc.RBBN logoRBBNRibbon Communicat…TENB logoTENBTenable Holdings,…
RevenueTrailing 12 months$1.3B$444M$685M$826M$1.0B
EBITDAEarnings before interest/tax$447M$47M$241M$40M$72M
Net IncomeAfter-tax profit$251M$47M$201M$31M-$12M
Free Cash FlowCash after capex-$185M$105M$290M$17M$263M
Gross MarginGross profit ÷ Revenue+83.1%+73.7%+83.1%+48.7%+78.2%
Operating MarginEBIT ÷ Revenue+33.3%+9.6%+33.7%-0.7%+2.9%
Net MarginNet income ÷ Revenue+19.4%+10.5%+29.4%+3.8%-1.2%
FCF MarginFCF ÷ Revenue-14.3%+23.6%+42.4%+2.0%+25.7%
Rev. Growth (YoY)Latest quarter vs prior year+19.2%+26.0%+9.8%-10.3%+9.6%
EPS Growth (YoY)Latest quarter vs prior year+81.6%+3.6%+10.1%-33.3%+106.3%
QLYS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — RBBN and TENB each lead in 3 of 6 comparable metrics.

At 12.2x trailing earnings, RBBN trades at a 82% valuation discount to AVPT's 68.8x P/E. On an enterprise value basis, RBBN's 9.6x EV/EBITDA is more attractive than TENB's 63.6x.

MetricINDV logoINDVIndivior Pharmace…AVPT logoAVPTAvePoint, Inc.QLYS logoQLYSQualys, Inc.RBBN logoRBBNRibbon Communicat…TENB logoTENBTenable Holdings,…
Market CapShares × price$4.9B$2.2B$3.3B$472M$2.5B
Enterprise ValueMkt cap + debt − cash$5.1B$1.8B$3.2B$781M$2.7B
Trailing P/EPrice ÷ TTM EPS24.15x68.80x17.45x12.23x-71.80x
Forward P/EPrice ÷ next-FY EPS est.12.65x27.75x12.87x20.69x11.06x
PEG RatioP/E ÷ EPS growth rate0.90x
EV / EBITDAEnterprise value multiple17.88x44.79x13.49x9.57x63.60x
Price / SalesMarket cap ÷ Revenue3.99x5.31x5.00x0.56x2.47x
Price / BookPrice ÷ Book value/share4.94x6.17x1.08x7.93x
Price / FCFMarket cap ÷ FCF27.32x10.98x18.13x9.69x
Evenly matched — RBBN and TENB each lead in 3 of 6 comparable metrics.

Profitability & Efficiency

AVPT leads this category, winning 5 of 9 comparable metrics.

QLYS delivers a 37.2% return on equity — every $100 of shareholder capital generates $37 in annual profit, vs $-4 for TENB. AVPT carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to TENB's 1.43x. On the Piotroski fundamental quality scale (0–9), AVPT scores 6/9 vs INDV's 4/9, reflecting solid financial health.

MetricINDV logoINDVIndivior Pharmace…AVPT logoAVPTAvePoint, Inc.QLYS logoQLYSQualys, Inc.RBBN logoRBBNRibbon Communicat…TENB logoTENBTenable Holdings,…
ROE (TTM)Return on equity+10.2%+37.2%+7.9%-3.7%
ROA (TTM)Return on assets+19.1%+6.3%+19.1%+2.7%-0.7%
ROICReturn on invested capital+3.4%+11.4%+47.5%+2.1%+0.2%
ROCEReturn on capital employed+79.1%+8.1%+37.8%+2.4%+0.1%
Piotroski ScoreFundamental quality 0–946655
Debt / EquityFinancial leverage0.02x0.17x0.90x1.43x
Net DebtTotal debt minus cash$156M-$471M-$153M$309M$278M
Cash & Equiv.Liquid assets$195M$481M$250M$96M$188M
Total DebtShort + long-term debt$351M$10M$97M$405M$466M
Interest CoverageEBIT ÷ Interest expense10.88x-0.02x1.02x
AVPT leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

INDV leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in INDV five years ago would be worth $36,837 today (with dividends reinvested), compared to $3,899 for RBBN. Over the past 12 months, INDV leads with a +244.9% total return vs AVPT's -40.0%. The 3-year compound annual growth rate (CAGR) favors AVPT at 32.6% vs TENB's -16.2% — a key indicator of consistent wealth creation.

MetricINDV logoINDVIndivior Pharmace…AVPT logoAVPTAvePoint, Inc.QLYS logoQLYSQualys, Inc.RBBN logoRBBNRibbon Communicat…TENB logoTENBTenable Holdings,…
YTD ReturnYear-to-date+10.8%-21.9%-27.5%-7.2%-5.2%
1-Year ReturnPast 12 months+244.9%-40.0%-25.6%-11.8%-31.2%
3-Year ReturnCumulative with dividends+97.0%+133.0%-17.7%+1.9%-41.1%
5-Year ReturnCumulative with dividends+268.4%+1.7%-3.1%-61.0%-41.9%
10-Year ReturnCumulative with dividends+281.7%+5.5%+267.2%-68.2%-28.8%
CAGR (3Y)Annualised 3-year return+25.4%+32.6%-6.3%+0.6%-16.2%
INDV leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — INDV and QLYS each lead in 1 of 2 comparable metrics.

QLYS is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than RBBN's 1.49 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. INDV currently trades 96.6% from its 52-week high vs AVPT's 51.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricINDV logoINDVIndivior Pharmace…AVPT logoAVPTAvePoint, Inc.QLYS logoQLYSQualys, Inc.RBBN logoRBBNRibbon Communicat…TENB logoTENBTenable Holdings,…
Beta (5Y)Sensitivity to S&P 5000.68x1.06x0.53x1.49x1.12x
52-Week HighHighest price in past year$41.00$20.25$155.47$4.29$35.69
52-Week LowLowest price in past year$10.63$8.83$74.51$1.80$15.73
% of 52W HighCurrent price vs 52-week peak+96.6%+51.0%+61.1%+62.7%+60.4%
RSI (14)Momentum oscillator 0–10079.654.154.254.360.1
Avg Volume (50D)Average daily shares traded2.6M1.6M773K879K3.0M
Evenly matched — INDV and QLYS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: INDV as "Buy", AVPT as "Buy", QLYS as "Hold", RBBN as "Buy", TENB as "Buy". Consensus price targets imply 69.6% upside for AVPT (target: $18) vs 12.8% for INDV (target: $45).

MetricINDV logoINDVIndivior Pharmace…AVPT logoAVPTAvePoint, Inc.QLYS logoQLYSQualys, Inc.RBBN logoRBBNRibbon Communicat…TENB logoTENBTenable Holdings,…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuyBuy
Price TargetConsensus 12-month target$44.67$17.50$134.30$3.50$27.94
# AnalystsCovering analysts31248828
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+0.2%+2.2%+5.5%+1.9%+10.0%
Insufficient data to determine a leader in this category.
Key Takeaway

QLYS leads in 1 of 6 categories (Income & Cash Flow). AVPT leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallIndivior Pharmaceuticals Inc (INDV)Leads 1 of 6 categories
Loading custom metrics...

INDV vs AVPT vs QLYS vs RBBN vs TENB: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is INDV or AVPT or QLYS or RBBN or TENB a better buy right now?

For growth investors, AvePoint, Inc.

(AVPT) is the stronger pick with 26. 9% revenue growth year-over-year, versus 1. 3% for Ribbon Communications Inc. (RBBN). Ribbon Communications Inc. (RBBN) offers the better valuation at 12. 2x trailing P/E (20. 7x forward), making it the more compelling value choice. Analysts rate Indivior Pharmaceuticals Inc (INDV) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — INDV or AVPT or QLYS or RBBN or TENB?

On trailing P/E, Ribbon Communications Inc.

(RBBN) is the cheapest at 12. 2x versus AvePoint, Inc. at 68. 8x. On forward P/E, Tenable Holdings, Inc. is actually cheaper at 11. 1x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — INDV or AVPT or QLYS or RBBN or TENB?

Over the past 5 years, Indivior Pharmaceuticals Inc (INDV) delivered a total return of +268.

4%, compared to -61. 0% for Ribbon Communications Inc. (RBBN). Over 10 years, the gap is even starker: INDV returned +281. 7% versus RBBN's -68. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — INDV or AVPT or QLYS or RBBN or TENB?

By beta (market sensitivity over 5 years), Qualys, Inc.

(QLYS) is the lower-risk stock at 0. 53β versus Ribbon Communications Inc. 's 1. 49β — meaning RBBN is approximately 181% more volatile than QLYS relative to the S&P 500. On balance sheet safety, AvePoint, Inc. (AVPT) carries a lower debt/equity ratio of 2% versus 143% for Tenable Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — INDV or AVPT or QLYS or RBBN or TENB?

By revenue growth (latest reported year), AvePoint, Inc.

(AVPT) is pulling ahead at 26. 9% versus 1. 3% for Ribbon Communications Inc. (RBBN). On earnings-per-share growth, the picture is similar: Indivior Pharmaceuticals Inc grew EPS 108. 3% year-over-year, compared to 3. 2% for Tenable Holdings, Inc.. Over a 3-year CAGR, AVPT leads at 21. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — INDV or AVPT or QLYS or RBBN or TENB?

Qualys, Inc.

(QLYS) is the more profitable company, earning 29. 6% net margin versus -3. 6% for Tenable Holdings, Inc. — meaning it keeps 29. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: QLYS leads at 33. 2% versus 0. 1% for TENB. At the gross margin level — before operating expenses — QLYS leads at 82. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is INDV or AVPT or QLYS or RBBN or TENB more undervalued right now?

On forward earnings alone, Tenable Holdings, Inc.

(TENB) trades at 11. 1x forward P/E versus 27. 7x for AvePoint, Inc. — 16. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVPT: 69. 6% to $17. 50.

08

Which pays a better dividend — INDV or AVPT or QLYS or RBBN or TENB?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is INDV or AVPT or QLYS or RBBN or TENB better for a retirement portfolio?

For long-horizon retirement investors, Qualys, Inc.

(QLYS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53), +267. 2% 10Y return). Both have compounded well over 10 years (QLYS: +267. 2%, RBBN: -68. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between INDV and AVPT and QLYS and RBBN and TENB?

These companies operate in different sectors (INDV (Healthcare) and AVPT (Technology) and QLYS (Technology) and RBBN (Communication Services) and TENB (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: INDV is a small-cap quality compounder stock; AVPT is a small-cap high-growth stock; QLYS is a small-cap deep-value stock; RBBN is a small-cap deep-value stock; TENB is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

INDV

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 11%
Run This Screen
Stocks Like

AVPT

High-Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Net Margin > 6%
Run This Screen
Stocks Like

QLYS

Quality Mega-Cap Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 17%
Run This Screen
Stocks Like

RBBN

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Gross Margin > 29%
Run This Screen
Stocks Like

TENB

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 46%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform INDV and AVPT and QLYS and RBBN and TENB on the metrics below

Revenue Growth>
%
(INDV: 19.2% · AVPT: 26.0%)
Net Margin>
%
(INDV: 19.4% · AVPT: 10.5%)
P/E Ratio<
x
(INDV: 24.1x · AVPT: 68.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.